Cuba's Nasalferon provides optimal results to fight Covid-19
Cubans who received Nasalferon drug in February (99.4 percent of 100,000) have shown optimal results to fight Covid-19.
- Written by Redacción ¡ahora!
- Category: Health
- Hits: 1239
Cubans who received Nasalferon drug in February (99.4 percent of 100,000) have shown optimal results to fight Covid-19.
This city in eastern Cuba is preparing today for the third phase of clinical trials of the Abdala Covid-19 vaccine candidate, which it will share with Guantanamo, after conducting two previous ones with good results.
During the meeting of the Temporary Working Group for the prevention and control of the COVID epidemic, headed by the Cuban President Miguel Díaz-Canel Bermúdez, the Second Secretary of the Communist Party of Cuba José Ramón Machado Ventura and Prime Minister Manuel Marrero Cruz, the Cuban deputy prime minister stressed that last week Cuba, recorded the third 7-day period of dismal results regarding positive COVID-19 cases, since the pandemic was declared nearly one year ago.
As many as 44,010 persons will volunteer from today in the clinical trial of Cuba´s Soberana 02 vaccine candidate that enters phase-3.